Insider Transactions in Q4 2021 at Bio Techne Corp (TECH)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 19
2021
|
Kim Kelderman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
500
-60.0%
|
$252,000
$504.77 P/Share
|
Nov 19
2021
|
Kim Kelderman Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$75,000
$150.78 P/Share
|
Nov 16
2021
|
Norman David Eansor President-Protein Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
799
+27.4%
|
$99,875
$125.05 P/Share
|
Nov 12
2021
|
Norman David Eansor President-Protein Sciences |
SELL
Open market or private sale
|
Direct |
27,159
-21.45%
|
$13,688,136
$504.35 P/Share
|
Nov 12
2021
|
Norman David Eansor President-Protein Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
27,159
+48.82%
|
$3,394,875
$125.05 P/Share
|
Nov 02
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
200
-1.83%
|
$105,000
$525.1 P/Share
|
Nov 02
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+1.79%
|
$25,000
$125.05 P/Share
|
Nov 01
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
8,822
-13.79%
|
$4,649,194
$527.04 P/Share
|
Nov 01
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,822
+31.06%
|
$1,102,750
$125.05 P/Share
|
Oct 29
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
662
-5.8%
|
$347,550
$525.23 P/Share
|
Oct 29
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
662
+5.48%
|
$82,750
$125.05 P/Share
|
Oct 28
2021
|
Alpna Seth Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+7.68%
|
-
|
Oct 28
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
100
-0.92%
|
$52,500
$525.18 P/Share
|
Oct 28
2021
|
Julie L Bushman Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+22.35%
|
-
|
Oct 28
2021
|
Rupert Vessey Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+13.65%
|
-
|
Oct 28
2021
|
Joseph D Keegan Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+7.68%
|
-
|
Oct 28
2021
|
Roeland Nusse Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+2.71%
|
-
|
Oct 28
2021
|
John L Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+4.04%
|
-
|
Oct 28
2021
|
Randolph C Steer Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+3.53%
|
-
|
Oct 28
2021
|
Robert V Baumgartner Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+1.94%
|
-
|
Oct 26
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
BUY
Bona fide gift
|
Indirect |
2,660
+50.0%
|
-
|
Oct 26
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
SELL
Bona fide gift
|
Direct |
2,660
-19.3%
|
-
|